University of Tokyo

The quarterly Venture Monitor report from Pitchbook and the National Venture Capital Association (NVCA) reported biopharma start-ups raised $5.9bn in the first quarter of 2024 – more than the sector r

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. GSK Teams With Ideaya On Synthetic Leth

Biopharma start-ups brought in nearly two-and-a-half times as much funding in the fourth quarter as in the third quarter. Novartis AG was one of five big pharma companies to pen an alliance with a

Through its innovation labs, JLABS program and JLINX incubator effort, Johnson & Johnson is using a variety of methods to generate its own discovery work, but its Johnson & Johnson Innovation arm